FOR IMMEDIATE RELEASE March 19, 2025 – The International Cardio-Oncology Society (ICOS) is pleased to announce the publication of a pivotal whitepaper titled “Cardio-oncology rehabilitation and exercise: evidence, priorities, and recommendations” in...
The Journal of the American College of Cardiology (JACC) recently announced the appointment of Dr. Anju Nohria, MD, MSc, as a new Associate Editor. Dr. Nohria brings a wealth of expertise and a passion for advancing cardiovascular health to this pivotal role. A...
The Global Cardio-Oncology Summit is the flagship annual meeting for anyone interested in this field. This year's meeting will be hosted by the team from Virginia Commonwealth University's Pauley Heart Center. Drs. Wendy Bottinor and Fadi Salloum highlight some of the key themes and distinguishing features of this event. Basic science and nursing components will […]
Joshua Levenson MD is an Assistant Professor of Medicine at the University of Pittsburgh School of Medicine. He studied Chemistry at Amherst College followed by medicine at the University of Pittsburgh and internal medicine residency at The University of Michigan. He returned to the University of Pittsburgh Medical Center for Cardiology Fellowship prior to joining […]
Dr. Isabella Mahe is the first author of the API-CAT trial and in this episode she reviews predictors associated with clinically relevant bleeding. Join us for for an in-depth discussion on predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism: a post-hoc analysis of a randomised, non-inferiority trial (API-CAT).
Dr. Suvro Banerjee is a distinguished Cardiologist based in Kolkata, West Bengal, with an impressive experience of 26 years in the field of cardiology. Holding multiple prestigious qualifications including MBBS, MD, MRCP, FRCP, FICC, FCSI, FESC, FACC, and FSCAI. As a testament to his leadership and dedication to the field, he has held several notable […]
Join Dr Emily Tomasulo (Pennsylvania Hospital, US) and Dr Robert S. Copeland Halperin (Northwell Health System, US) for an in-depth discussion on BTK Inhibitor-Associated Hypertension.